当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:247.07亿  总市值:248.68亿
流通股本:9.16亿   总股本:9.22亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润4.41亿元,每股收益0.48元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1516729.75万元,未分配利润1062436.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1833349.76万元,负债316620.00万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,525,389,316.38,016,894,756.635,805,134,511.24,034,400,209.97
营业总成本1,106,091,598.545,388,666,480.383,879,965,357.382,717,305,015.54
营业利润502,324,358.52,862,889,616.442,119,657,580.921,457,791,851.67
利润总额514,669,004.462,978,246,258.992,233,497,637.21,567,658,696.03
净利润441,292,666.662,536,706,331.491,907,346,070.631,341,293,924.9
其他综合收益----
综合收益总额441,292,666.662,536,706,331.491,907,346,070.631,341,293,924.9
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计14,637,024,658.9214,702,020,835.0414,349,997,698.3414,220,305,969.65
非流动资产合计3,696,472,919.443,757,473,071.423,801,778,486.463,829,257,623.54
资产总计18,333,497,578.3618,459,493,906.4618,151,776,184.818,049,563,593.19
流动负债合计2,966,636,587.833,538,200,163.23,853,827,559.34,324,975,644.58
非流动负债合计199,563,460.58194,867,404.54202,812,952.7193,714,003
负债合计3,166,200,048.413,733,067,567.744,056,640,5124,518,689,647.58
归属于母公司股东权益合计15,141,767,178.414,701,852,74914,071,197,838.7813,508,465,658.86
股东权益合计15,167,297,529.9514,726,426,338.7214,095,135,672.813,530,873,945.61
负债和股东权益合计18,333,497,578.3618,459,493,906.4618,151,776,184.818,049,563,593.19
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计2,682,585,478.499,721,019,491.227,739,228,359.65,820,320,494.26
经营活动现金流出小计1,888,681,002.717,544,582,475.445,999,715,661.264,253,044,328.18
经营活动产生的现金流量净额793,904,475.782,176,437,015.781,739,512,698.341,567,276,166.08
投资活动现金流入小计917,852,231.985,119,418,9462,745,625,237.742,460,034,964.49
投资活动现金流出小计927,049,337.567,159,335,473.354,822,222,826.314,515,635,215.97
投资活动产生的现金流量净额-9,197,105.58-2,039,916,527.35-2,076,597,588.57-2,055,600,251.48
筹资活动现金流入小计283,631,958.411,441,663,600.751,159,785,934.41787,815,312.94
筹资活动现金流出小计322,581,170.932,646,804,155.552,037,620,537.421,561,160,398.44
筹资活动产生的现金流量净额-38,949,212.52-1,205,140,554.8-877,834,603.01-773,345,085.5
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额745,758,157.68-1,068,620,066.37-1,214,919,493.24-1,261,669,170.9
期末现金及现金等价物余额7,415,120,901.396,669,362,743.716,523,063,316.846,476,313,639.18
最新报告期:2025-05-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,董晓洁2.342.602.862025-05-08
国投证券马帅2.442.702.972025-05-01
国联民生郑薇,陈翠琼2.803.083.352025-04-29
开源证券余汝意,巢舒然2.232.482.752025-04-28
国金证券袁维2.462.773.132025-04-27
TOP↑